SERPINB4 and neoplasm: Moreover, mutations in SERPINB3 (16% vs. 3%, p < .001) and SERPINB4 (13% vs. 4%, p < .01) were more frequent in high ITS than low ITS group, which might promote serpin protein misfolding to increase tumor immunogenicity.34